NCT02793466 2023-09-22
Durvalumab in Pediatric and Adolescent Patients
Children's Hospital Los Angeles
Phase 1 Completed
Clinical Trials
3 trialsNCT02336165 2022-10-12
Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
Ludwig Institute for Cancer Research
Phase 2 Completed
NCT02794883 2022-04-18
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
Northwestern University
Phase 2 Completed